Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X014729 | — |
No additional AE; administration of an expired dose of PNEUMOVAX-23 on 18-MAR-2025; This spontaneous report was received from a registered nurse and refers to a 51-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-MAR-2025, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), (lot #X014729, expiration date: 22-Nov-2024), 1 dose/once (strength, dose, anatomical location not reported) for prophylaxis. No symptomatic adverse events were reported. There were no temperature excursions during the product lifetime.